QURE- Uniqure N.V.

Name: Uniqure N.V. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Uniqure N.V. (QURE) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. QURE is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Abi-Saab Walid	150.4K	$4.15M	-
Other	Potts Jeannette	106.5K	$2.94M	-
CFO	Klemt Christian	63.9K	$1.76M	-
Dir	Gut Robert	40.1K	$1.11M	-
Dir	Meek David D.	39.7K	$1.10M	-1,993

Activity

Buys and sells only

Transactions

10 filings · page 13

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 17, 2021	Kapusta Matthew C64	CEO, CFO, Managing Director	Sell	2,250	$33.16	$74,616.72	-0.3%	-0.3%	-50.5%
Mar 2, 2021	Kapusta Matthew C64	CEO, CFO, Managing Director	Sell	4,974	$36.94	$183,739.56	-1.8%	-	-
Mar 2, 2021	Meek David D.51	Director	Sell	505	$37.50	$18,937.50	-7.3%	-	-
Mar 2, 2021	Gut Robert69	Director	Sell	1,300	$36.98	$48,074.00	-3.0%	-	-
Mar 2, 2021	Kuta Alexander Edward III81	Executive VP, Operations	Sell	1,206	$37.00	$44,622.00	-1.7%	-	-
Mar 2, 2021	Klemt Christian58	Chief Accounting Officer	Sell	1,350	$37.03	$49,990.50	-2.1%	-	-
Mar 2, 2021	Springhorn Jeremy P.52	Director	Sell	505	$37.50	$18,937.50	-4.8%	-	-
Mar 2, 2021	Balachandran Madhavan52	Director	Sell	505	$37.50	$18,937.50	-4.8%	-	-
Mar 2, 2021	Soteropoulos Paula75	Director	Sell	504	$37.60	$18,950.40	-7.3%	-	-
Mar 2, 2021	Astley-Sparke Philip47	Director	Sell	504	$37.60	$18,950.40	-4.8%	-	-

← PrevPage 13Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC